Helius Medical Technologies, Inc. - Class A Common Stock (HSDT)
0.3096
-0.0659 (-17.55%)
NASDAQ · Last Trade: Jun 17th, 6:25 PM EDT
Detailed Quote
Previous Close
0.3755
Open
0.3456
Bid
0.3198
Ask
0.3200
Day's Range
0.3044 - 0.3600
52 Week Range
0.3608 - 24.00
Volume
8,304,166
Market Cap
1.15M
PE Ratio (TTM)
-0.0980
EPS (TTM)
-3.2
Dividend & Yield
N/A (N/A)
1 Month Average Volume
13,356,557
Chart
About Helius Medical Technologies, Inc. - Class A Common Stock (HSDT)
Helius Medical Technologies is focused on developing and commercializing innovative medical devices aimed at improving treatment options for patients with neurological conditions, particularly those suffering from disorders resulting from traumatic brain injuries. The company's flagship product is designed to enhance the brain's natural ability to heal itself by leveraging neurotechnology. Helius is committed to advancing the field of neurology through rigorous scientific research and collaborations, ultimately aiming to improve outcomes and quality of life for affected individuals. Read More
Curious to know what's happening on the US markets one hour before the close of the markets on Monday? Join us as we explore the top gainers and losers in today's session.
Curious to know what's happening on the US markets one hour before the close of the markets on Thursday? Join us as we explore the top gainers and losers in today's session.
Stay up-to-date with the latest market trends in the middle of the day on Thursday. Explore the top gainers and losers during today's session in our detailed report.
-PoNS Therapeutic Experience Program (PoNSTEP) study demonstrates durable long-term beneficial effects of PoNS Therapy® on gait deficit improvement in people with Multiple Sclerosis-
Stay up-to-date with the latest market trends one hour before the close of the markets on Wednesday. Explore the top gainers and losers during today's session in our detailed report.
Helius Medical Technologies (NASDAQ:HSDT) shares are trading higher Wednesday after the company announced an authorized claim for payment for the PoNS Device from Aetna Healthcare.
